Submit Deal

MIRADOR THERAPEUTICS

Summary

Mirador is a next-generation precision medicine company focused on immunology and inflammation.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 314 M

Avg. Deal Size£ 314 M

Market Context

Senior Management

Sort

Target: MIRADOR THERAPEUTICS

Bidder: ORBIMED ADVISORS LLC

4 Service Providers

7 Dealmakers

£ 314 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy